Starpharma Holdings Limited (ASX:SPL)

Starpharma Holdings Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 16, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	42	39	127	302	607	419
Market Cap Growth	-34.30%	-69.24%	-57.90%	-50.21%	44.84%	-17.09%
Enterprise Value	24	10	91	255	538	385
Last Close Price	0.10	0.10	0.31	0.74	1.50	1.13
PS Ratio	10.06	4.01	29.30	58.55	174.10	58.91
PB Ratio	1.80	1.39	3.66	6.25	9.74	13.38
P/TBV Ratio	1.80	1.39	3.66	6.25	9.74	13.38
EV/Sales Ratio	5.78	1.04	20.97	49.34	154.38	54.13
Debt / Equity Ratio	0.11	0.13	0.24	0.17	0.02	0.05
Asset Turnover	0.11	0.22	0.07	0.07	0.06	0.16
Inventory Turnover	3.94	4.13	4.42	6.36	14.33	35.16
Quick Ratio	4.93	4.46	3.00	5.65	6.61	5.40
Current Ratio	5.41	4.94	3.26	5.93	6.78	5.48
Return on Equity (ROE)	-43.46%	-25.95%	-37.59%	-29.19%	-42.15%	-39.82%
Return on Assets (ROA)	-21.28%	-11.48%	-16.53%	-14.48%	-21.96%	-20.86%
Return on Capital (ROIC)	-24.76%	-13.66%	-19.61%	-16.82%	-25.60%	-24.36%
Earnings Yield	-29.94%	-20.86%	-12.29%	-5.34%	-3.25%	-3.50%
FCF Yield	-26.74%	-18.05%	-11.73%	-4.63%	-2.48%	-2.60%
Buyback Yield / Dilution	-0.96%	-0.59%	-0.53%	-2.53%	-6.62%	-0.25%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.